Fund moves

Pfizer (PFE): Gulf International Bank (UK) Ltd added to its stake +12K shares

Gulf International Bank (UK) Ltd added to its stake in Pfizer, per its Q2 2026 13F.

451K
Shares reported · +12K vs prior quarter
0.21%
Disclosed portfolio weight
$10.9M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 13, 2026

What stands out in this filing

  • 438,730 shares in Q1 2026, 450,940 now (+2.8% in share count).
  • Reported at $10.9M, 0.21% of the portfolio value in this 13F filing.
  • 95 other tracked managers reported the same kind of change for Q2 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 26, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  2. Mar 10, 2025CongressDisclosed sale of PFE — reported range $15,001 - $50,000
  3. Mar 24, 2026CongressDisclosed sale of PFE — reported range $50,001 - $100,000
  4. Jun 8, 2026CongressDisclosed sale of PFE — reported range $15,001 - $50,000
  5. Jun 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 16, 2026, Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026 for a professional opportunity outside of the pharmaceutical industry in consumer goods, and that his departure is not related to the Company’s financial or operating results or to any disagreements with the Company regarding the Company’s financial,…”
  6. Jun 24, 2026FDAFDA drug approval: Ibrance
  7. Jun 24, 2026FDAFDA drug approval: Ibrance
  8. Jul 6, 2026Government · Federal Register noticeEndo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
  9. Jul 15, 2026Federal contract · $5K obligatedDepartment of Defense awarded Pfizer: $4.9K obligated to date
  10. Jul 20, 2026Government · Federal Register noticeForeign-Trade Zone (FTZ) 43, Notification of Proposed Production Activity; Pfizer Inc.; (Pharmaceutical Products); Kalamazoo and Portage, Michigan
  11. Jul 30, 2026Federal contract · $4K obligatedDepartment of Defense awarded Pfizer: $3.9K obligated to date
  12. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
  13. Aug 5, 2026Insider · 3 peopleInsiders: 2 purchases (~$2.0M), 1 sale (~$83K)
  14. Aug 12, 2026Insider · Their first buy on recordCEO purchased ~$1M of PFE shares in the open market

What came next

  1. Aug 21, 2026Government · Federal Register noticeAdvisory Committee; Oncologic Drugs Advisory Committee; Renewal
  2. Sep 4, 2026FDARecall: Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC…
  3. Sep 25, 2026Government · Federal Register noticeJeffrey Thies: Final Debarment Order
  4. Sep 29, 2026FDARecall: Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC…
  5. Sep 29, 2026FDARecall: Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC…
  6. Oct 7, 2026FDAFDA drug approval: Tukysa
  7. Oct 26, 2026FDAFDA drug approval: Talzenna
  8. Oct 26, 2026FDAFDA drug approval: Talzenna
  9. Oct 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 3, 2026, Pfizer Inc. (the “Company”) announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026 (the “Effective Date”).”
  10. Nov 3, 2026Company filing · Form 8-K · ResultsReported its results
  11. Nov 13, 2026Government · Federal Register noticeDetermination That DIBENZYLINE (Phenoxybenzamine Hydrochloride) Oral Capsule, 10 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Pfizer

For Pfizer, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.

How this filing works

Explore the data

Common questions

What does this filing report about Pfizer (PFE) stock?

Gulf International Bank (UK) Ltd added to its stake in Pfizer, per its Q2 2026 13F. Now 451K shares, $10.9M reported value, 0.21% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2026. Filed: Aug 13, 2026.

What stands out in this filing?

438,730 shares in Q1 2026, 450,940 now (+2.8% in share count). Reported at $10.9M, 0.21% of the portfolio value in this 13F filing. 95 other tracked managers reported the same kind of change for Q2 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Pfizer recently?

For Pfizer, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the PFE page.

Does this mean PFE stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Pfizer

Everything OQRO holds on this company is on its PFE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data